A prognostic index (PI) as a moderator of outcomes in the treatment of depression: A proof of concept combining multiple variables to inform risk-stratified stepped care models

Journal of Affective Disorders

Volumn 213, Issue , 2017, Pages 78-85

  Lorenzo Luaces, Lorenzo ^a   DeRubeis, Robert J ^a   van Straten, Annemieke ^b   Tiemens, Bea ^c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d Pro Persona Research   (Netherlands)

Author keywords

Depression; Personalized medicine; Prognosis; Psychotherapy; Stepped care

Indexed keywords

ADULT; ARTICLE; BRIEF THERAPY; CLINICAL OUTCOME; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; CONVALESCENCE; DEPRESSION; DISEASE SEVERITY; EMOTIONALITY; FEMALE; FOLLOW UP; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROGNOSTIC INDEX; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; UNEMPLOYMENT; COGNITIVE THERAPY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SHORT TERM PSYCHOTHERAPY; STATISTICAL MODEL; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; COGNITIVE THERAPY; DEPRESSION; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY, BRIEF; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85012104663     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.02.010     Document Type: Article

References (69)

1. Akay, C.L., Meric-Bernstam, F., Hunt, K.K., Grubbs, E.G., Bedrosian, I., Tucker, S.L. Buchholz, T.A., Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann. Surg. Oncol. 19 (2012), 901–907, 10.1245/s10434-011-2006-7.
2. American Psychiatric Association, Diagnostic and Statistical Manual Of Mental Disorders, 2000, American Psychiatric Association, Washington, DC (revised 4th ed.).
3. Andreescu, C., Mulsant, B.H., Houck, P.R., Whyte, E.M., Mazumdar, S., Dombrovski, A.Y., Reynolds III, M., Charles, F., Empirically derived decision trees for the treatment of late-life depression. Am. J. Psychiatry 165 (2008), 855–862, 10.1176/appi.ajp.2008.07081340.
4. Barbui, C., Cipriani, A., Patel, V., Ayuso-Mateos, J.L., van Ommeren, M., Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br. J. Psychiatry 198 (2011), 11–16, 10.1192/bjp.bp.109.076448.
5. Barth, J., Munder, T., Gerger, H., Nüesch, E., Trelle, S., Znoj, H., Cuijpers, P., Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med., 10(5), 2013, e1001454, 10.1371/journal.pmed.1001454.
6. Bell, E.C., Marcus, D.K., Goodlad, J.K., Are the parts as good as the whole? A meta-analysis of component treatment studies. J. Consult. Clin. Psychol. 81 (2013), 722–736, 10.1037/a0033004.
7. Bockting, C.L., Smid, N.H., Koeter, M.W., Spinhoven, P., Beck, A.T., Schene, A.H., Enduring effects of Preventive Cognitive Therapy in adults remitted from recurrent depression: A 10 year follow-up of a randomized controlled trial. J. Affect. Disord. 185 (2015), 188–194, 10.1016/j.jad.2015.06.048.
8. Chen, A.M., Meric‐Bernstam, F., Hunt, K.K., Thames, H.D., Outlaw, E.D., Strom, E.A., Singletary, S.E., Breast conservation after neoadjuvant chemotherapy. Cancer 103 (2005), 689–695, 10.1002/cncr.20815.
9. Chen, A.M., Meric-Bernstam, F., Hunt, K.K., Thames, H.D., Oswald, M.J., Outlaw, E.D. Singletary, S.E., Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J. Clin. Oncol. 22 (2004), 2303–2312, 10.1200/JCO.2004.09.062.
10. Cloitre, M., Petkova, E., Su, Z., Weiss, B., Patient characteristics as a moderator of post-traumatic stress disorder treatment outcome: combining symptom burden and strengths. Br. J. Psychiatry Open 2 (2016), 101–106, 10.1192/bjpo.bp.115.000745.
11. Costa, P.T., MacCrae, R.R., Revised NEO Personality Inventory (NEO PI-R) and NEO Five-factor Inventory (NEO FFI): Professional Manual. 1992, Psychological Assessment Resources, Odessa, FL.
12. Cuijpers, P., van Straten, A., Andersson, G., van Oppen, P., Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J. Consult. Clin. Psychol. 76 (2008), 909–922, 10.1037/a0013075.
13. Cuijpers, P., Donker, T., van Straten, A., Li, J., Andersson, G., Is guided self-help as effective as face-to-face psychotherapy for depression and anxiety disorders? A systematic review and meta-analysis of comparative outcome studies. Psychol. Med. 40 (2010), 1943–1957, 10.1017/S0033291710000772.
14. Cuijpers, P., Donker, T., Johansson, R., Mohr, D.C., van Straten, A., Andersson, G., Self-guided psychological treatment for depressive symptoms: a meta-analysis. PLoS One, 6, 2011, e21274, 10.1371/journal.pone.0021274.
15. Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S.D., van Straten, A., The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J. Affect. Disord. 159 (2014), 118–126, 10.1016/j.jad.2014.02.026.
16. Delgadillo, J., Moreea, O., Lutz, W., Different people respond differently to therapy: a demonstration using patient profiling and risk stratification. Behav. Res. Ther. 79 (2016), 15–22, 10.1016/j.brat.2016.02.003.
17. Derogatis, L.R., Symptom Checklist-90-R Administration, Scoring and Procedures Manual II. 1983, Clinical Psychometric Research, Towson, MD.
18. DeRubeis, R.J., Gelfand, L.A., German, R.E., Fournier, J.C., Forand, N.R., Understanding processes of change: how some patients reveal more than others – and some groups of therapists less – about what matters in psychotherapy. Psychother. Res. 24 (2014), 419–428, 10.1080/10503307.2013.838654.
19. DeRubeis, R.J., Cohen, Z.D., Forand, N.R., Fournier, J.C., Gelfand, L.A., Lorenzo-Luaces, L., The Personalized advantage index: translating research on prediction into individualized treatment recommendations. A demonstration. PLoS One, 9, 2014, e83875, 10.1371/journal.pone.0083875.
20. Dew, M.A., Reynolds, C.F., Houck, P.R., Hall, M., Buysse, D.J., Frank, E., Kupfer, D.J., Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch. Gen. Psychiatry 54 (1997), 1016–1024, 10.1001/archpsyc.1997.01830230050007.
21. Dimidjian, S., Hollon, S.D., Dobson, K.S., Schmaling, K.B., Kohlenberg, R.J., Addis, M.E., Gollan, J.K., Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J. Consult. Clin. Psychol. 74 (2006), 658–670, 10.1037/0022-006X.74.4.658.
22. Driessen, E., Cuijpers, P., Hollon, S.D., Dekker, J.J., Does pretreatment severity moderate the efficacy of psychological treatment of adult outpatient depression? A meta-analysis. J. Consult. Clin. Psychol. 78 (2010), 668–680, 10.1037/a0020570.
23. Driessen, E., Smits, N., Dekker, J., Peen, J., Don, F., Kool, S., Van, H., Differential efficacy of cognitive behavioral therapy and psychodynamic therapy for major depression: a study of prescriptive factors. Psychol. Med., 2016, 731–744, 10.1017/S0033291715001853.
24. Elkin, I., Gibbons, R.D., Shea, M.T., Sotsky, S.M., Watkins, J.T., Pilkonis, P.A., Hedeker, D., Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J. Consult. Clin. Psychol., 63, 1995, 841, 10.1037/0022-006X.63.5.841.
25. Flückiger, C., Del Re, A.C., Munder, T., Heer, S., Wampold, B.E., Enduring effects of evidence-based psychotherapies in acute depression and anxiety disorders versus treatment as usual at follow-up—a longitudinal meta-analysis. Clin. Psychol. Rev. 34 (2014), 367–375, 10.1016/j.cpr.2014.05.001.
26. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C., Fawcett, J., Antidepressant drug effects and depression severity. JAMA 303 (2010), 47–53, 10.1001/jama.2009.1943.
27. Garber, J., Weersing, V., Hollon, S., Porta, G., Clarke, G., Dickerson, J., Shamseddeen, W., Prevention of depression in at-risk adolescents: moderators of long-term response. Prev. Sci., 2016, 1–10, 10.1007/s11121-015-0626-z.
28. Goldberg, D., Bridges, K., Duncan-Jones, P., Grayson, D., Detecting anxiety and depression in general medical settings. BMJ 297 (1988), 897–899, 10.1136/bmj.297.6653.897.
29. Guo, P., Zeng, F., Hu, X., Zhang, D., Zhu, S., Deng, Y., Hao, Y., Improved variable selection algorithm using a LASSO-type penalty, with an application to assessing Hepatitis B infection relevant factors in community residents. PLoS ONE, 10, 2015, e0134151, 10.1371/journal.pone.0134151.
30. Harrell, F.E. Jr, Regression Modeling Strategies: with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2001, Springer, New York, NY.
31. Hayes, A.F., Matthes, J., Computational procedures for probing interactions in OLS and logistic regression: SPSS and SAS implementations. Behav. Res. Methods 41 (2009), 924–936, 10.3758/BRM.41.3.924.
32. Hollon, S.D., DeRubeis, R.J., Fawcett, J., Amsterdam, J.D., Shelton, R.C., Zajecka, J., Gallop, R., Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry 71 (2014), 1157–1164, 10.1001/jamapsychiatry.2014.
33. Huang, E.H., Strom, E.A., Perkins, G.H., Oh, J.L., Chen, A.M., Meric-Bernstam, F., Buchholz, T.A., Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int. J. Radiat. Oncol. Biol. Phys. 66 (2006), 352–357, 10.1016/j.ijrobp.2006.04.046.
34. Huibers, M.J., Cohen, Z.D., Lemmens, L.H., Arntz, A., Peeters, F.P., Cuijpers, P., DeRubeis, R.J., Predicting optimal outcomes in cognitive therapy or interpersonal psychotherapy for depressed individuals using the personalized advantage index approach. PLoS One, 10, 2015, e0140771, 10.1371/journal.pone.0140771.
35. Jarrett, R.B., Minhajuddin, A., Kangas, J.L., Friedman, E.S., Callan, J.A., Thase, M.E., Acute phase cognitive therapy for recurrent major depressive disorder: who drops out and how much do patient skills influence response?. Behav. Res. Ther. 51 (2013), 221–230, 10.1016/j.brat.2013.01.006.
36. Kang, C., Janes, H., Huang, Y., Combining biomarkers to optimize patient treatment recommendations. Biometrics 70 (2014), 695–707, 10.1111/biom.12191.
37. Karyotaki, E., Smit, Y., Beurs, D.P., Henningsen, K.H., Robays, J., Huibers, M.J., Cuijpers, P., The long‐term efficacy of acute‐phase psychotherapy for depression: a meta‐analysis of randomized trials. Depress. Anxiety 33 (2016), 370–383, 10.1002/da.22491.
38. Kessler, R., van Loo, H., Wardenaar, K., Bossarte, R., Brenner, L., Ebert, D., Sampson, N., Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder. Epidemiology and psychiatric sciences. Adv. Online Publ., 2016, 10.1017/S2045796016000020.
39. Kessler, R., van Loo, H., Wardenaar, K., Bossarte, R., Brenner, L., Cai, T., de Jonge, P., Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports. Molecular psychiatry. Adv. Online Publ., 2016, 10.1038/mp.2015.198.
40. Khan, A., Leventhal, R.M., Khan, S.R., Brown, W.A., Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J. Clin. Psychopharmacol. 22 (2002), 40–45, 10.1097/00004714-200202000-00007.
41. Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., Brown, W.A., A systematic review of comparative efficacy of treatments and controls for depression. PloS ONE, 7, 2012, e41778.
42. Kirsch, I., Deacon, B.J., Huedo-Medina, T.B., Scoboria, A., Moore, T.J., Johnson, B.T., Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med., 5, 2008, e45, 10.1371/journal.pmed.0050045.
43. Kirsch, I., Sapirstein, G., Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prev. T. 2a., 1998, 10.1037/1522-3736.1.1.12a.
44. Kocsis, J.H., Gelenberg, A.J., Rothbaum, B., Klein, D.N., Trivedi, M.H., Manber, R., Thase, M.E., Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J. Affect. Disord. 110 (2008), 55–61, 10.1016/j.jad.2008.01.002.
45. Kraemer, H.C., Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Stat. Med. 32 (2013), 1964–1973, 10.1002/sim.5734.
46. Lawlor, D.A., Hopker, S.W., The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ, 322(7289), 2001, 763, 10.1136/bmj.322.7289.763.
47. Lecrubier, Y., Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies. J. Clin. Psychiatry, 68(suppl 2), 2007 (478-441).
48. Lorenzo-Luaces, L., Heterogeneity in the prognosis of major depression: from the common cold to a highly debilitating and recurrent illness. Epidemiol. Psychiatr. Sci. 24 (2015), 466–472, 10.1017/S2045796015000542.
49. Lorenzo-Luaces, L., DeRubeis, R.J., Bennett, I.M., Primary care physicians' selection of low-intensity treatments for patients With depression. Fam. Med. 47 (2015), 511–516.
50. Lovell, K., Richards, D., Multiple access points and levels of entry (maple): ensuring choice, accessibility and equity for CBT services. Behav. Cogn. Psychother. 28 (2000), 379–391.
51. Luty, S.E., Carter, J.D., McKenzie, J.M., Rae, A.M., Frampton, C.M., Mulder, R.T., Joyce, P.R., Randomised controlled trial of interpersonal psychotherapy and cognitive–behavioural therapy for depression. Br. J. Psychiatry 190 (2007), 496–502, 10.1192/bjp.bp.106.024729.
52. Morris, A.D., Morris, R.D., Wilson, J.F., White, J., Steinberg, S., Okunieff, P. Van Dongen, J.A., Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J. Sci. Am. 3 (1997), 6–12, 10.1016/j.cpr.2014.05.001.
53. National Institute for Clinical Excellence Depression, 2004. Management of Depression in Primary and Secondary Care. National Institute for Clinical Excellence.
54. Nelson, J.C., Delucchi, K.L., Schneider, L.S., Moderators of outcome in late-life depression: a patient-level meta-analysis. Am. J. Psychiatry 170 (2013), 651–659, 10.1176/appi.ajp.2012.12070927.
55. Parker, G., Beyond major depression. Psychol. Med. 35 (2005), 467–474, 10.1017/S0033291704004210.
56. Rush, A., Wisniewski, S.R., Warden, D., et al. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch. Gen. Psychiatry 65 (2008), 870–880, 10.1001/archpsyc.65.8.870.
57. Stekhoven, D.J., Bühlmann, P., MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics 28 (2012), 112–118, 10.1093/bioinformatics/btr597.
58. Thase, M.E., Greenhouse, J.B., Frank, E., Reynolds, C.F., Pilkonis, P.A., Hurley, K., Kupfer, D.J., Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch. Gen. Psychiatry 54 (1997), 1009–1015, 10.1001/archpsyc.1997.01830230043006.
59. Tibshirani, R., Regression shrinkage and selection via the lasso. J. R. Stat. Soc. Ser. B (Methodol.) 58 (1996), 267–288, 10.1111/j.1467-9868.2011.00771.x.
60. Tibshirani, R., Regression shrinkage and selection via the lasso: a retrospective. J. R. Stat. Soc.: Ser. B (Stat. Methodol.) 73 (2011), 273–282, 10.1111/j.1467-9868.2011.00771.x.
61. Tiemens, B.G., 1999. Management of mental health problems in primary care. The doctor, the Patient, and the Medical Model. University of Groningen.
62. Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., McGrath, P.J., Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry, 2006, 10.1176/appi.ajp.163.1.28.
63. Troxel, W.M., Kupfer, D.J., Reynolds, C.F. III, Frank, E., Thase, M.E., Miewald, J.M., Buysse, D.J., Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. J. Clin. Psychiatry 73 (2011), 478–485, 10.4088/JCP.11m07184.
64. van Dongen, J.A., Voogd, A.C., Fentiman, I.S., Legrand, C., Sylvester, R.J., Tong, D. Bartelink, H., Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer I. 92 (2000), 1143–1150, 10.1093/jnci/92.14.1143.
65. Van Straten, A., Tiemens, B., Hakkaart, L., Nolen, W., Donker, M., Stepped care vs. matched care for mood and anxiety disorders: a randomized trial in routine practice. Acta Psychiatr. Scand. 113 (2006), 468–476, 10.1111/j.1600-0447.2005.00731.x.
66. Waljee, A.K., Mukherjee, A., Singal, A.G., Zhang, Y., Warren, J., Balis, U., Higgins, P.D., Comparison of imputation methods for missing laboratory data in medicine. BMJ OPEN, 3, 2013, e002847, 10.1136/bmjopen-2013-002847.
67. Wallace, M.L., Frank, E., Kraemer, H.C., A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials. JAMA Psychiatry 70 (2013), 1241–1247, 10.1001/jamapsychiatry.2013.1960.
68. Wampold, B.E., Budge, S.L., Laska, K.M., Del Re, A.C., Baardseth, T.P., Flűckiger, C. Gunn, W., Evidence-based treatments for depression and anxiety versus treatment-as-usual: A meta-analysis of direct comparisons. Clin. Psychol. Rev. 31:8 (2011), 1304–1312, 10.1016/j.cpr.2011.07.012.
69. Wittchen, H.-U., Robins, L.N., Semler, W.J., Cottler, L., World Health Organization, Composite International Diagnostic Interview (CIDI): interviewer's Manual. 1993, World Health Organization, Geneva, Switzerland.